Type 2 & other diabetes

Gender and socioeconomic inequalities in the cascade of type 2 diabetes care trends among middle-aged and older Chinese

Diabetes Res Clin PractPublished Repeated cross-sectional study

Main finding · T2DM prevalenceResult — go to the resultAdjusted odds ratio 1.09-1.17

Authors' conclusion

Rising T2DM prevalence, persistent SES disparities, and widening gender gaps highlight the need for targeted interventions-particularly for women, low-SES individuals, and treatment-stage improvement.

Study context

Population
Middle-aged and older Chinese adults, China Health and Retirement Longitudinal Study (CHARLS), 2011–2020per wave
Participants
11,059-14,789 participants
Exposure
Women vs men; socioeconomic status
Outcome
T2DM care cascade: prevalence, awareness, treatment and control
Follow-up
2011-2020
Methodological detailsfive waves (2011-2020), nationally based longitudinal survey data (CHARLS)
  • Five waves (2011-2020)
  • Nationally based longitudinal survey data (CHARLS)

Main finding

T2DM prevalence

Adjusted odds ratio

1.09-1.17

By group

Women

12.8 % to 22.4 %

Men

12.0 % to 21.5 %

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeaOR
Awareness · 2011-20201.18-1.31

Awareness · 2011-2020

Awareness increased over time, particularly among women
Socioeconomic inequalities in awareness narrowed

Treatment

Patients remaining untreated
over 60 %
Socioeconomic inequalities widened in women's treatment (relative index (RII))
1.22-1.45
Persistent socioeconomic status (SES) disparities in treatment

Control

Control rates showed little gender or SES difference

Original publication

Gender and socioeconomic inequalities in the cascade of type 2 diabetes care trends among middle-aged and older Chinese. Diabetes Res Clin Pract. Published 19 November 2025. doi:10.1016/j.diabres.2025.113008

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.